Cargando…
来那度胺治疗复发难治性多发性骨髓瘤57例临床观察
OBJECTIVE: To investigate the clinical efficacy and safety of lenalidomide (Revlimid, R) - based chemotherapy in the treatment of relapsed/refractory multiple myeloma (MM) patients. METHODS: 57 consecutively relapsed/refractory MM patients were retrospectively analyzed from June 2013 to February 201...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342977/ https://www.ncbi.nlm.nih.gov/pubmed/28655091 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.005 |
Ejemplares similares
-
来那度胺治疗多发性骨髓瘤相关血栓事件的临床分析
Publicado: (2016) -
泊马度胺治疗复发/难治性多发性骨髓瘤的疗效、安全性研究
Publicado: (2023) -
伊沙佐米、来那度胺、地塞米松治疗复发/难治多发性骨髓瘤的疗效与安全性分析:一项国内多中心真实世界研究
Publicado: (2021) -
硼替佐米、泊马度胺、地塞米松方案治疗复发/难治性多发性骨髓瘤的疗效及安全性
Publicado: (2023) -
来那度胺联合硼替佐米和地塞米松诱导治疗初诊多发性骨髓瘤患者的疗效和安全性
Publicado: (2022)